This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
One of the privileges that have come with building Drug Hunter has been all the insightful thoughts and commentary our…
Article
12 months ago ●
5 mins read
Context. “Compound 3” (UCSF) is a covalent KRASG12R inhibitor used as a proof-of-concept for covalent arginine modification. KRAS is the…
molecule
6 months ago ●
5 mins read
There were six small molecule candidates disclosed on Apr. 10th at AACR New Orleans 2022 at the New Drugs on…
Article
12 months ago ●
4 mins read
Context. “Compound 19” (Janssen) is an oral dihydroorotate dehydrogenase (DHODH) inhibitor being developed for acute myelogenous leukemia (AML). DHODH is…
molecule
6 months ago ●
5 mins read
It’s always nice to see a small molecule making the front page of the news, especially when it’s a Molecule…
Article
12 months ago ●
2 mins read
Context. “Compound 23” (Merck) is a selective oral cathepsin K (CatK) inhibitor intended for osteoarthritis. Osteoarthritis affects around 15% of…
molecule
6 months ago ●
4 mins read
Load More
